Professional Documents
Culture Documents
•GABA receptor •GABA receptor •GABA receptor •GABA receptor •Inhibit NMDA
agonist causing ↑ Cl agonist causing ↑ Cl agonist causing ↑ Cl agonist causing ↑ Cl receptor
influx influx influx influx
•A – inactive orally •A – 44% oral •A –inactive orally •A – 100% oral •A – 20% oral
•D – 98% protein bioavailability •D – 76% protein bioavailability bioavailability
bound •D – 96% protein bound. Short •D – 60% protein •D – 50% protein
•M – liver bound duration of action bound. 40% in RBCs. bound. Short
•E – urine. t1/2 = 10- •M – liver due to redistribution Rapid onset due to duration due to
60 minutes •E – urine. t1/2 = 2-4 •M – plasma and lipophilic and less redistribution
hours hepatic esterase ionized •M – liver
•E – urine and bile. •M – liver •E – urine and bile.
t1/2 = 2-4 hours •E – urine and bile. t1/2 = 2-3 hours
t1/2 = 3-22 hours
Others
Analgesia Opioids
• Moderate agonists
-codeine
-loperamide
-tramadol***
• Mixed agonist+antagonists
NSAIDs -nalbuphine
-buprenorphine
• Non-specific COX inhibitors
-aspirin • Antagonists
-diclofenac -naloxone
-mefenamic acid -naltrexone
-ibuprofen
•u, k and δ opioid •u (main), k and δ •u, k and δ opioid •u, k and δ opioid •Weak u, k and δ
receptor agonist at opioid receptor receptor agonist at receptor agonist at opioid receptor
spinal and agonist at spinal and spinal and spinal and agonist.
supraspinal level supraspinal level supraspinal level supraspinal level •α receptor
•Stimulates histamine •Minimal histamine •Less histamine •Stimulates histamine antagonist
release*** release release*** release*** •5-HT agonist
•0.05-0.1 mg/kg •0.5-1 ug/kg •0.5-1 mg/kg •Drug of abuse •1-2 mg/kg
-tiagabine
GABA mimetics
-direct stimulation of GABA
receptors
-barbiturates
-benzodiazepines
-propofol
Drugs acting on NMDA-ergic
neurons
-phenytoin -ethosuximide
-carbamazepine
-lamotrigine
Others
-valproate -acts on both GABA and NMDA receptors and Na channel
-levetiracetam - unknown
Class I (Na channel blocker) Class III (K channel blocker)
• Ia – quinidine, procainamide -amiodarone
• Ib – lignocaine, mexiletine -sotalol
• Ic – flecainide, propafenone
Class V (Others)
-adenosine
-Mg
-K
-digoxin
-atropine
Centrally acting
-α2 agonists
α2 agonists
-methyldopa Heart
-clonidine -B blockers
Anti-HTN
B blockers
• Non specific
- +ISA -oxyprenolol
- -ISA -propranolol, timolol,
sotalol
• B1 specific
- +ISA -celeprolol
- -ISA -metoprolol, esmolol,
bisoprolol, atenolol
• + α1 blocking property
-labetolol
• α1 antagonists
Kidney -prazosin, terazosin, phentolamine,
-diuretics phenoxybenzamine
• ACE inhibitors
-captopril, perindopril, enalapril
Diuretics
• AT-II blockers
• Loop diuretics -losartan, valsartan, candersatan
-frusemide, bumetanide
• CCB
• Thiazides -dihydropyridine - amlodipine,
-HCTZ nifedipine
-nondihydropyridine - verapamil,
• K-sparing diuretic diltiazem
-spironolactone
• Vasodilators
• CA inhibitor -GTN, hydralazine, nitroprusside
-acetazolamide
• Osmotic diuretic
-mannitol
Blood vessels
-α1 antagonists
-ACE inhibitors
-AT-II blockers
-CCB
-vasodilator
Anti-platelet
Anti-coagulant
Streptokinase
-not a protease (no enzymatic activity)
-binds to plasminogen (free and clot-bound) to form a
complex and releases plasmin
-↑ fibrinolysis and fibrinogenolysis Thrombolytics
Synthetic
-dobutamine
-isoprenaline
-dopexamine
Non catecholamines
-ephidrine
-phenylephrine
B2 agonists Muscarinic antagonists
• Long acting
-salmeterol
-formeterol
Methylxanthines
• Catecholamines
-adrenaline -theophylline
-Na chromoglycate
Corticosteroids
Lipoxygenase inhibitors
• Systemic
-zileuton -hydrocortisone
-prednisolone
Diuretics
Osmotic diuretics
-mannitol
-isosorbide
-urea
-glycerine
• Intermediate acting
-humulin N, novolin N
Anti-DM
• Long acting Insulin secretagogues
-glargine, determir
• Sulphonylureas
-1st gen - tolbutamide
-2nd gen - gliclazide, glibenclamide
• Meglitinides
Biguanides
-repaglinide
-metformin
• D-phenylalanine derivative
-nateglinide
α glucosidase inhibitors
-acarbose, miglitol
Corticosteroids
Cell wall synthesis inhibitors Cephalosporins
-penicillin
-cephalosporins • 1st generation
-B-lactamase inhibitors -cefazolin, cephalexin
• 4th generation
-cefepime
Penicillin
• Penicillin Others
-penicillin V, pencillin G,
benzathine penicillin • Carbapenem
-imipenem, meropenem
• Anti-staphylococcal
-cloxacillin, methicillin, nafcillin • Monobactam
-aztreonam
• Extended spectrum
-amoxicillin, ampicillin, • Glycopeptide
piperacillin, -vancomycin
B lactamase inhibitors
-clavulanic acid, tazobactam,
sulbactam
Free radical generator Nucleic acid synthesis inhibitors
-metronidazole -folate antagonist
-nitrofurantoin - DNA gyrase inhibitor
- RNA polymerase inhibitor
- Free radical generator
• Sulfonamides
-sulfamethoxazole, sulfadiazine,
sulfasalazine
DNA gyrase inhibitors
• Pyrimidines
• Fluroquinolones -trimethoprim
-ciprofloxacin, levofloxacin,
ofloxacin
50s inhibitors
• Macrolides
-azithromycin, clarithromycine,
erythromycin
Chloramphenicol
Clindamycin
Oxazolidinones
-linezolid
• 50s inhibitor
30s inhibitor -macrolides
-chloramphenicol
• Aminoglycosides -clindamycin
-gentamycin, neomycin, -oxazolidinones
streptomycin
• 30s inhibitor
• Tetracycline -aminoglycosides
-doxycycline, demeclocycline -tetracycline
Synthesis
Lipoxygenase inhibitors
-zileuton
Phospholipase C inhibitors
-costicosteroids
Leukotrine receptor
antagonists
-zafirlukast
-montelukast
• Anti-inflammatory PG
- PGE2, PGI2
• Pro-inflammatory PG
- PGD2, PGF2, TXA2
-all leukotrines
Leukotrines Vasoconstriction
Bronchospasm ↑ mucus
secretion and oedema
Eosinophilia and chemotaxis